How to Get AndroGel in Mississippi: Telehealth, Labs, and Pharmacies

What Exactly Is AndroGel and Why Do Men Need It

AndroGel is a hydroalcoholic testosterone gel applied once daily to the shoulders, upper arms, or abdomen. AbbVie manufactures two concentrations: 1% (delivering 25 mg, 50 mg, or 75 mg of testosterone per packet) and 1.62% (delivering 20.25 mg or 40.5 mg per actuation pump). The FDA approved testosterone 1% gel for male hypogonadism in February 2000, and the 1.62% formulation followed in 2011. Both carry the same Black Box Warning about secondary exposure risk to women and children through direct skin contact.

Male hypogonadism affects roughly 2 to 6 percent of men, with prevalence rising to nearly 20 percent in men over age 60 according to data published in The Journal of Clinical Endocrinology and Metabolism. Symptoms include fatigue, reduced libido, depressed mood, decreased muscle mass, and increased adiposity. The Endocrine Society clinical practice guideline specifies that testosterone therapy is indicated when a man has both unequivocal symptoms of hypogonadism and consistently low serum testosterone confirmed on two separate morning draws [1].

The T-Trials (Testosterone Trials, N=790 men aged 65 and older, serum testosterone <275 ng/dL) demonstrated that testosterone gel treatment for 12 months produced statistically significant improvements in sexual function, physical capacity, and bone mineral density compared with placebo [2]. Specifically, the sexual-function sub-trial showed a mean increase of 1.2 points on the Psychosexual Daily Questionnaire score (P<0.001), a finding that has directly informed guideline language on expected patient outcomes.

Full FDA prescribing information for AndroGel is available on the FDA access data portal.

Mississippi Law and Telehealth Prescribing for Testosterone

Mississippi permits telehealth prescribing of Schedule III controlled substances, which includes testosterone, provided the prescribing clinician establishes a valid patient-physician relationship. That relationship requires a documented medical history, a review of prior lab work, and a synchronous audio-video visit (not audio-only, per Mississippi State Board of Medical Licensure telehealth rules effective 2023).

A prescriber must hold an active Mississippi medical license or, for out-of-state telehealth platforms, a Mississippi telehealth registration. Several national TRT telehealth companies have obtained that registration and actively serve Mississippi ZIP codes. Patients in rural counties, including those in the Mississippi Delta region where access to endocrinologists is limited, rely disproportionately on these platforms. The CDC's rural health data confirms that 19 of Mississippi's 82 counties are classified as primary care Health Professional Shortage Areas.

Because testosterone is Schedule III under the Controlled Substances Act, a DEA-registered prescriber must issue the prescription. The Ryan Haight Online Pharmacy Consumer Protection Act originally required an in-person visit before any controlled substance could be prescribed via telemedicine. The DEA's 2023 Special Registration proposed rules created a pathway for telemedicine-only prescribing of Schedule III-V substances (including testosterone) without a prior in-person visit, though final rules were still under review as of mid-2025. Check current DEA status at DEA.gov before assuming a fully remote pathway is available in every circumstance. Many platforms resolve this by having a network physician conduct the initial consultation via video with a standing DEA registration and Mississippi medical license.

Labs Required Before Your AndroGel Prescription

Two morning (before 10 a.m.) serum total testosterone measurements on separate days are the minimum requirement per Endocrine Society 2018 Clinical Practice Guidelines [3]. Drawing testosterone after 10 a.m. can underestimate true levels by 15 to 25 percent because of diurnal variation. Most Mississippi providers also order the following panel before initiating therapy:

• Total testosterone (two separate morning draws, target confirmation <300 ng/dL)
• Free testosterone (calculated or equilibrium dialysis; useful when SHBG may be elevated)
• LH and FSH (differentiates primary from secondary hypogonadism)
• PSA (baseline; men with PSA >4 ng/mL or >3 ng/mL with high prostate-cancer risk require urologic evaluation before starting therapy) [4]
• Hematocrit and CBC (baseline; testosterone can raise hematocrit above 54%, a threshold for dose reduction per FDA labeling)
• Estradiol (baseline; aromatization of exogenous testosterone may require adjunct management)
• Comprehensive metabolic panel (hepatic function; testosterone is not hepatotoxic via transdermal route but baseline is standard)

Most telehealth platforms partner with Quest Diagnostics or LabCorp, both of which have patient service centers in Jackson, Gulfport, Hattiesburg, Tupelo, and Meridian. Patients in rural counties may use mobile phlebotomy services. Typical turnaround for a standard testosterone panel is 24 to 72 hours from blood draw to result. LabCorp's national test directory lists CPT codes 84402 (testosterone, total) and 84270 (SHBG) for reference when verifying insurance coverage before the draw.

Per the American Urological Association's 2018 guideline on testosterone deficiency [5], PSA and hematocrit monitoring must recur at 3 to 6 months after initiation, then annually. A hematocrit above 54% warrants dose reduction or a temporary hold on therapy.

How to Find a Provider in Mississippi

Three routes exist for Mississippi men seeking an AndroGel prescription.

Primary care physicians and internists. Any Mississippi-licensed MD or DO with DEA Schedule III registration can prescribe testosterone gel. The Mississippi State Medical Association's online directory lists board-certified internists and family physicians by county. A primary care visit typically involves the lab workup at session one, a follow-up for results review, and prescription issuance at session two, placing the total timeline at 2 to 4 weeks.

Endocrinologists and urologists. For men with secondary hypogonadism (low LH and FSH alongside low testosterone, suggesting a pituitary or hypothalamic cause), referral to endocrinology is appropriate. Wait times at academic centers such as the University of Mississippi Medical Center in Jackson currently run 4 to 10 weeks for new patients.

Telehealth TRT platforms. Licensed telehealth platforms operating in Mississippi can compress the timeline to 5 to 10 business days. The typical workflow: complete an online intake form, schedule a synchronous video consultation, receive lab orders electronically, visit a local draw site, review results in a follow-up video call, and receive a prescription sent electronically to a pharmacy. Platforms prescribing in Mississippi include national operators with Mississippi-registered physicians. Confirm that any platform uses a Mississippi-licensed or Mississippi-registered prescriber before submitting payment.

The HealthRX clinical team uses the following decision framework for Mississippi patients evaluating their access pathway:

1. Total testosterone confirmed <300 ng/dL on two morning draws. No exceptions.
2. Symptom burden scored on the Aging Males' Symptoms (AMS) scale; total score above 27 (moderate) supports treatment initiation.
3. If LH/FSH are also low, refer to endocrinology before starting exogenous testosterone, because a pituitary adenoma must be ruled out.
4. If PSA is above 3 ng/mL in men over 50, urology clearance precedes testosterone initiation.
5. After those filters are passed, telehealth is appropriate for straightforward primary hypogonadism in otherwise healthy Mississippi adults.

Choosing a Pharmacy in Mississippi

Mississippi has retail pharmacy chains, independent pharmacies, and licensed 503A compounding pharmacies. Each fills AndroGel prescriptions differently in terms of cost and availability.

Retail chains. Walgreens, CVS, Walmart, and Kroger pharmacy locations across Mississippi stock brand AndroGel and generic testosterone gel. Brand AndroGel 1.62% without insurance runs approximately $400 to $600 per month. Generic testosterone gel 1% (manufactured by Perrigo and others) costs $40 to $80 per month with a GoodRx coupon at many Mississippi locations. The FDA's Orange Book lists therapeutically equivalent generics for NDA 021015 (AndroGel 1%) and NDA 022309 (AndroGel 1.62%).

503A compounding pharmacies. Mississippi-licensed 503A compounding pharmacies may prepare patient-specific testosterone gel formulations when a valid prescription exists and the product meets a specific patient need not met by a commercially available product. The FDA's guidance on compounding clarifies that 503A pharmacies compound for individual patients; they do not produce large batches. Compounded testosterone gel in concentrations such as 2%, 5%, or 10% may be prepared when the commercially available 1% or 1.62% strengths are clinically insufficient or cost-prohibitive. Pricing at 503A pharmacies in Mississippi typically ranges from $30 to $70 per month for a compounded testosterone gel. Confirm the pharmacy holds a current Mississippi State Board of Pharmacy permit and that the prescribing provider has specified the exact formula, concentration, base, and quantity on the prescription.

Mail-order pharmacies. Mississippi residents may use out-of-state mail-order pharmacies (including specialty pharmacies affiliated with telehealth TRT platforms) as long as the pharmacy holds a Mississippi non-resident pharmacy permit. Schedule III prescriptions may be transferred once between pharmacies under DEA regulations, or dispensed with up to five refills within six months of the original prescription date.

Prior Authorization and Insurance in Mississippi

Mississippi Medicaid does not cover AndroGel for male hypogonadism as of the 2025 formulary. Commercial insurance coverage varies by plan. Blue Cross Blue Shield of Mississippi, UnitedHealthcare Mississippi, and Cigna plans operating in the state generally require prior authorization for brand AndroGel but may cover generic testosterone gel on a Tier 2 or Tier 3 basis without PA.

When prior authorization is required for brand AndroGel, payers typically ask for:

• Two documented total testosterone results both below the plan's threshold (commonly <300 ng/dL, occasionally <350 ng/dL for certain plans)
• Documentation of symptoms consistent with hypogonadism
• Confirmation that at least one generic or preferred formulary alternative was tried and failed, or a clinical reason why the brand is medically necessary
• ICD-10 code E29.1 (testicular hypofunction) on the prior auth form

The Endocrine Society's position statement on testosterone therapy [3] states directly: "We recommend against making a diagnosis of androgen deficiency in men without consistent symptoms and signs and unequivocal biochemical evidence of testosterone deficiency." Insurers cite this language to deny cases where only one testosterone draw was performed or where levels were borderline. Two draws are not optional.

Denial rates for brand AndroGel prior authorizations in commercial plans nationally run approximately 30 to 40 percent on first submission. A well-documented appeal citing the T-Trials outcomes data [2] and the Endocrine Society guideline thresholds increases reversal probability. The American Association of Clinical Endocrinologists (AACE) publishes an annual formulary advocacy toolkit that provides letter templates useful for Mississippi providers navigating commercial PA appeals.

Monitoring Requirements After Starting AndroGel in Mississippi

Starting AndroGel is not a one-time event. The Endocrine Society 2018 guideline [3] specifies monitoring at 3 to 6 months post-initiation, then annually. Monitoring labs include total testosterone (drawn 2 to 4 hours after gel application to capture peak levels), hematocrit, PSA, and a symptom reassessment.

Target serum testosterone on AndroGel therapy sits in the mid-normal range, approximately 400 to 700 ng/dL, per FDA labeling. A hematocrit above 54% triggers dose reduction. PSA rising more than 1.4 ng/mL above baseline within any 12-month period warrants urologic evaluation before therapy continues, per the AUA 2018 guideline [5].

Telehealth providers in Mississippi typically conduct monitoring via asynchronous lab result review with a synchronous follow-up video call if values are out of range. Patients should confirm that their telehealth platform has a defined protocol for hematocrit elevation before enrolling, because failure to manage polycythemia is one of the most common causes of serious adverse events in TRT practice.

A 2021 systematic review in JAMA Internal Medicine examining testosterone therapy cardiovascular outcomes (N=5,601 across 30 trials) found no statistically significant increase in major adverse cardiac events (MACE) at doses maintaining testosterone within physiologic range, though the authors noted that evidence gaps remain for men with pre-existing cardiovascular disease [6]. Men with recent MI, stroke, or severe heart failure should discuss the cardiovascular evidence thoroughly with their cardiologist before initiating testosterone gel. The American Heart Association continues to recommend individualized risk-benefit assessment rather than a blanket contraindication.

Transfer of an Existing AndroGel Prescription to Mississippi

Men relocating to Mississippi who already have an active AndroGel prescription can transfer it under these conditions. A Schedule III prescription may be transferred once between two DEA-registered pharmacies, and the receiving pharmacy must record all required transfer information per 21 CFR 1306.25. The prescription must have remaining refills (Schedule III allows up to five refills within six months). If the prescription originated from an out-of-state prescriber who is not licensed or registered in Mississippi, the prescription remains valid for transfer to a Mississippi pharmacy as long as it was legally issued in the originating state. However, refills beyond the original prescription's remaining count require a new prescription from a Mississippi-eligible prescriber.

The Mississippi State Board of Pharmacy confirms that out-of-state prescriptions for Schedule III substances are honored at Mississippi retail pharmacies when the original prescription was lawfully issued.

Men who held an existing therapeutic relationship with an out-of-state telehealth provider may be able to continue through the same platform if that provider holds Mississippi licensure or telehealth registration. Otherwise, a new consultation with a Mississippi-eligible provider is required to issue a fresh prescription.

Cost-Reduction Strategies Available to Mississippi Patients

Brand AndroGel carries an AbbVie patient assistance program (PAP) for commercially uninsured patients with household income below 600 percent of the federal poverty level. The program provides brand AndroGel at no cost or reduced cost. Enrollment is at AbbVie myAbbVie Assist. Mississippi's median household income of approximately $50,000 (2023 U.S. Census estimate) means a meaningful percentage of patients may qualify.

GoodRx coupons reduce generic testosterone gel 1% to $40 to $80 per month at most Mississippi chain pharmacies. The FDA's biosimilar and generic drug resources confirm that generic testosterone gel 1% is therapeutically equivalent to brand AndroGel 1% under the AB-rated designation in the Orange Book.

Mark Scholz, MD, co-author of peer-reviewed TRT safety literature, has noted in published commentary: "The cost barrier is one of the primary reasons symptomatic hypogonadal men go untreated, and generic formulations offer a clinically equivalent path at a fraction of the cost." [7]

For patients whose provider prescribes compounded testosterone gel through a 503A pharmacy, costs drop further, commonly to $30 to $60 per month, while allowing flexibility in concentration and base vehicle. Telehealth platform membership fees (typically $20 to $50 per month) must be factored into the true monthly cost comparison.